Colgate-Palmolive (NYSE:CL) Shares Bought by Platform Technology Partners

Platform Technology Partners boosted its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 16.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,784 shares of the company’s stock after acquiring an additional 2,103 shares during the quarter. Platform Technology Partners’ holdings in Colgate-Palmolive were worth $1,235,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. J.P. Morgan Private Wealth Advisors LLC acquired a new stake in Colgate-Palmolive in the third quarter valued at $8,411,000. Sepio Capital LP grew its position in shares of Colgate-Palmolive by 20.9% during the third quarter. Sepio Capital LP now owns 4,583 shares of the company’s stock worth $326,000 after acquiring an additional 793 shares during the last quarter. D.A. Davidson & CO. increased its holdings in shares of Colgate-Palmolive by 0.4% in the 3rd quarter. D.A. Davidson & CO. now owns 104,397 shares of the company’s stock valued at $7,424,000 after acquiring an additional 394 shares during the period. Charles Schwab Investment Management Inc. raised its position in Colgate-Palmolive by 0.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,348,751 shares of the company’s stock valued at $309,234,000 after purchasing an additional 34,546 shares during the last quarter. Finally, Burney Co. boosted its stake in Colgate-Palmolive by 6.9% during the 3rd quarter. Burney Co. now owns 19,322 shares of the company’s stock worth $1,374,000 after purchasing an additional 1,249 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CL. Barclays raised their target price on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 30th. Stifel Nicolaus lifted their price target on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, April 29th. StockNews.com cut Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Wells Fargo & Company boosted their target price on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research report on Monday, April 29th. Finally, Royal Bank of Canada raised their price objective on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research note on Monday, April 29th. Three research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $92.94.

Get Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

Shares of NYSE:CL traded down $0.09 on Friday, hitting $93.89. The company’s stock had a trading volume of 2,596,198 shares, compared to its average volume of 4,501,969. The company has a market capitalization of $77.03 billion, a price-to-earnings ratio of 29.71, a price-to-earnings-growth ratio of 3.45 and a beta of 0.39. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $95.59. The stock’s 50-day moving average is $91.04 and its two-hundred day moving average is $85.43.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The company had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the business posted $0.73 EPS. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. On average, equities research analysts forecast that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Monday, April 22nd were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.13%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date was Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, insider Sally Massey sold 12,226 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the transaction, the insider now directly owns 3,181 shares in the company, valued at approximately $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.